The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues.

This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.

  • Explores the current state-of-the-art in the pharmaceutical industry and the global healthcare sector
  • Includes insights from world-leading figures in the pharmaceutical industry, healthcare sector, federal funding agencies, regulatory bodies, investment sector, entrepreneurship, intellectual property law, philanthropic organizations, and advocacy groups
  • Develops in-depth, original concepts, which have important implications in the understanding of, and search for, potential solutions to the world´s health care crisis
"1132565855"
The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues.

This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.

  • Explores the current state-of-the-art in the pharmaceutical industry and the global healthcare sector
  • Includes insights from world-leading figures in the pharmaceutical industry, healthcare sector, federal funding agencies, regulatory bodies, investment sector, entrepreneurship, intellectual property law, philanthropic organizations, and advocacy groups
  • Develops in-depth, original concepts, which have important implications in the understanding of, and search for, potential solutions to the world´s health care crisis
74.99 In Stock
The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

by Ibis Sanchez Serrano
The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care

by Ibis Sanchez Serrano

eBook

$74.99  $99.95 Save 25% Current price is $74.99, Original price is $99.95. You Save 25%.

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care develops the innovative core model, an organizational research and design paradigm and economic theory that proposes a collaborative approach to resolving global health issues and improving the productivity of drug development. The model proposes that scientific collaboration does not occur in an unstructured manner, but actually takes place within a highly structured order where knowledge is transferred, integrated and finally translated into commercial products. An understanding of this model will help solve the global pharmaceutical industry´s productivity problems and address important global health care and economic issues.

This book is useful to researchers, advanced students, regulators, and management in pharmaceutical industries, as well as healthcare professionals, those working in health economics, and those interested in scientific innovation processes.

  • Explores the current state-of-the-art in the pharmaceutical industry and the global healthcare sector
  • Includes insights from world-leading figures in the pharmaceutical industry, healthcare sector, federal funding agencies, regulatory bodies, investment sector, entrepreneurship, intellectual property law, philanthropic organizations, and advocacy groups
  • Develops in-depth, original concepts, which have important implications in the understanding of, and search for, potential solutions to the world´s health care crisis

Product Details

ISBN-13: 9780128142943
Publisher: Elsevier Science
Publication date: 06/04/2019
Sold by: Barnes & Noble
Format: eBook
Pages: 174
File size: 15 MB
Note: This product may take a few minutes to download.

About the Author

Ibis Sánchez-Serrano is a world-leading expert on global healthcare, pharmaceutical innovation, and translational science policy. He is a member of the Editorial Board of the journal Gender&the Genome and has written two books, The World’s Health Care Crisis: From the Laboratory Bench to the Patient’s Bedside (Elsevier, 2011) and The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care (Elsevier, 2019). Mr. Sánchez-Serrano has built a reputation amongst important international government bodies as an expert on the world’s healthcare crisis and the relevant solutions. He’s a frequent speaker on global health care and pharmaceutical development and received international recognitions for his work on global health care, including a “Fulbright Recognition Award” and media coverage including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur. His research interests include Health Care, Pharmaceuticals, Biotechnology, Public Health, Academia-Industry Relationship, Drug Discovery and Development, Organization and Management of R&D.

Table of Contents

Part I1. Introduction: the remarkable success story of the development of bortezomib2. Lessons from the development of bortezomib: the Core Model

Part II3. The “Core”: when innovation meets leadership 4. “The Bridge”: collaboration is the best catalyst to success5. “The Periphery”: the efficient use of underused societal resources

Part III6. Biopharmaceutical intellectual property, financial interests, and the Core Model7. Global health care crisis, the pharmaceutical industry, and the Core Model8. The Core Model, innovation, economic growth, development, and policy-making

Part IV9. Conclusion: the Core Model: a novel economic theory10. Epilogue: the Core Model and other industries

What People are Saying About This

From the Publisher

Introduces and explains an organizational research and development concept and economic theory to provide solutions to global health issues

From the B&N Reads Blog

Customer Reviews